Literature DB >> 29777489

Serum antibody response to Chlamydia trachomatis TroA and HtrA in women with tubal factor infertility.

T Rantsi1, P Joki-Korpela2, K Hokynar3, I Kalliala2,4, H Öhman5, H-M Surcel5,6, J Paavonen2, A Tiitinen2, M Puolakkainen3.   

Abstract

Persistent genital chlamydial infection may lead to tubal factor infertility (TFI). Chlamydia trachomatis TroA and HtrA are proteins expressed during persistent chlamydial infection in vitro. We studied serum IgG antibody response against these proteins by EIA in women with TFI and in subfertile women without tubal pathology. Altogether, 22 of 258 subfertile women (8.5%) had TFI which was unilateral in 17 cases and bilateral in 5 cases. Overall, 55 (21.3%) of the 258 women had TroA and 39 (15.1%) had HtrA antibodies. Seropositivity to TroA and HtrA was more common among women with TFI than women with other causes for subfertility (45.5 vs. 19.1%, p = 0.004 for TroA; 36.4 vs. 13.1%, p = 0.004 for HtrA). Mean absorbance values and the prevalence of TroA and HtrA antibodies increased with increasing severity of TFI. On the basis of our results, TroA and HtrA serology has the potential to be further developed to a specific biomarker for C. trachomatis-related TFI.

Entities:  

Keywords:  Chlamydia trachomatis; HtrA; Persistent infection; Serology; TroA; Tubal factor infertility

Mesh:

Substances:

Year:  2018        PMID: 29777489     DOI: 10.1007/s10096-018-3276-9

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  12 in total

1.  Chlamydia trachomatis persistence in vitro: an overview.

Authors:  Priscilla B Wyrick
Journal:  J Infect Dis       Date:  2010-06-15       Impact factor: 5.226

Review 2.  Duration of untreated, uncomplicated Chlamydia trachomatis genital infection and factors associated with chlamydia resolution: a review of human studies.

Authors:  William M Geisler
Journal:  J Infect Dis       Date:  2010-06-15       Impact factor: 5.226

3.  Antibody to Chlamydia trachomatis proteins, TroA and HtrA, as a biomarker for Chlamydia trachomatis infection.

Authors:  K Hokynar; S Korhonen; P Norja; J Paavonen; M Puolakkainen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-09-14       Impact factor: 3.267

Review 4.  How to use Chlamydia antibody testing in subfertility patients.

Authors:  J A Land; J L Evers; V J Goossens
Journal:  Hum Reprod       Date:  1998-04       Impact factor: 6.918

5.  Proof of concept: A bioinformatic and serological screening method for identifying new peptide antigens for Chlamydia trachomatis related sequelae in women.

Authors:  Scott H Stansfield; Pooja Patel; Joseph Debattista; Charles W Armitage; Kelly Cunningham; Peter Timms; John Allan; Aruna Mittal; Wilhelmina M Huston
Journal:  Results Immunol       Date:  2013-05-13

Review 6.  CtHtrA: the lynchpin of the chlamydial surface and a promising therapeutic target.

Authors:  James W Marsh; Vanissa A Ong; William B Lott; Peter Timms; Joel DA Tyndall; Wilhelmina M Huston
Journal:  Future Microbiol       Date:  2017-06-08       Impact factor: 3.165

7.  Chlamydia trachomatis seropositivity is associated both with stillbirth and preterm delivery.

Authors:  M Gencay; M Koskiniemi; P Ammälä; V Fellman; A Närvänen; T Wahlström; A Vaheri; M Puolakkainen
Journal:  APMIS       Date:  2000-09       Impact factor: 3.205

Review 8.  Sexually transmitted infections: challenges ahead.

Authors:  Magnus Unemo; Catriona S Bradshaw; Jane S Hocking; Henry J C de Vries; Suzanna C Francis; David Mabey; Jeanne M Marrazzo; Gerard J B Sonder; Jane R Schwebke; Elske Hoornenborg; Rosanna W Peeling; Susan S Philip; Nicola Low; Christopher K Fairley
Journal:  Lancet Infect Dis       Date:  2017-07-09       Impact factor: 25.071

Review 9.  Hysterosalpingosonography for diagnosing tubal occlusion in subfertile women: a systematic review with meta-analysis.

Authors:  S Maheux-Lacroix; A Boutin; L Moore; M-E Bergeron; E Bujold; P Laberge; M Lemyre; S Dodin
Journal:  Hum Reprod       Date:  2014-02-26       Impact factor: 6.918

10.  Performance of the APTIMA Combo 2 assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in female urine and endocervical swab specimens.

Authors:  C A Gaydos; T C Quinn; D Willis; A Weissfeld; E W Hook; D H Martin; D V Ferrero; J Schachter
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

View more
  4 in total

Review 1.  What Can Serology Tell Us About the Burden of Infertility in Women Caused by Chlamydia?

Authors:  Patrick J Horner; Gloria E Anyalechi; William M Geisler
Journal:  J Infect Dis       Date:  2021-08-16       Impact factor: 5.226

2.  Predictive Values of Serum Chlamydia trachomatis TroA and HtrA IgG Antibodies as Markers of Persistent Infection in the Detection of Pelvic Adhesions and Tubal Occlusion.

Authors:  Tiina Rantsi; Jolande A Land; Päivi Joki-Korpela; Sander Ouburg; Kati Hokynar; Jorma Paavonen; Aila Tiitinen; Mirja Puolakkainen
Journal:  Microorganisms       Date:  2019-09-25

3.  C-reactive protein as a marker of persistent Chlamydia trachomatis infection is not associated with tubal factor infertility-an independent clinical validation study.

Authors:  Me Jansen; Ef van Ess; S Ouburg; Ml Gerds; Sa Morré; Ja Land
Journal:  Hum Reprod Open       Date:  2019-12-16

4.  Chlamydia trachomatis infection in the genital tract is associated with inflammation and hypospermia in the infertile male of China.

Authors:  Hua Zhou; Shunhong Wu; Xiaohua Tang; Guanqing Zhou; Jingru Yuan; Qing Li; Yaoyong Chen; Xia Xu; Xiaofang Sun; Detu Zhu; Yumei Luo
Journal:  Asian J Androl       Date:  2022 Jan-Feb       Impact factor: 3.285

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.